Day One

7.00am Registration & Morning Coffee

8:05 am Chair’s Opening Remarks

Gregory Fiore Chief Executive Officer, Exacis Biotherapeutics

Emergence of mRNA-Based Therapeutics & Vaccines 2.0

8:15 am Biopharma Leaders’ Fireside Chat – Evaluating Progress of mRNA Therapies in 2023: Where are we Succeeding & Where are the Gaps?

Gilles besin Chief Scientific Officer, Orbital Therapeutics
Helen McCarthy CEO, Phion Therapeutics Limited
PD Dr. Carsten Rudolph CEO, Ethris GmbH
Frank DeRosa Chief Technology Officer & Global Head of Research, mRNA Center of Excellence, Sanofi
Jason Zhang Chief Scientific Officer & Co-Founder, RVAC

Synopsis

Download the full event guide for full details.

9:00 am Moderna’s mRNA-1345 Vaccine in Older Adults

Sonia Stoszek Executive Director & Program Lead – RSV Vaccines, Moderna

Synopsis

Download the full event guide for full details.

9:30 am BioNTech’s Update on mRNA-Based Vaccines & Other mRNA-Based Therapeutics in Clinical Development

Michael Wenger Vice President - Clinical Development, BioNTech SE

Synopsis

Download the full event guide for full details.

10:00 am Assessing the Industry’s Landscape & Preparing for the Future

Aaron Larsen Senior Director & Technical Head - Nucleic Acid Franchise, Resilience Inc

Synopsis

Download the full event guide for full details.

10.30 Morning Break & Speed Networking

Track: Discovery
Chair Moderator: AJ Bergman, CFO, Capricor Therapeutics

Engineering Next-Generation mRNA Sequences to Expand Therapeutic Protein Expression

11.30 mRNA Sequence Optimization Effect on Protein Expression

Download the full event guide for full details.

Daniella Ishimaru, Principal Scientist, ReCode Therapeutics

12.00 Comprehensive Characterization of the mRNA-Lipid Nanoparticle by Multi-Capillary Electrophoresis & LC-MS

Download the full event guide for full details.

Matthew Stone, Advanced Workflow Specialist, Sciex

12.30 Longevity, the ADvantage Approach

Download the full event guide for full details.

Walter Schmidt, Director – mRNA Division, ADvantage Therapeutics

Track: Translation
Chair Moderator: Gregory Fiore, CEO, Exacis Biotherapeutics

Optimizing In Vivo Characterization of Onco-Selective mRNA to
Improve Tolerability & Immunogenicity

11.30 Onco-selective mRNA LNPs Enable a Wide Therapeutic Window in Preclinical Tumor Models

Download the full event guide for full details.

Manfred Kraus, VP - R&D, Kernal Bio

12.00 Multimodal Real-World Data for Accelerating Translational Research & De-Risking Drug Development:
RNA Seq in Precision Oncology

Download the full event guide for full details.

Joshua Bell, Senior Director - Enterprise Strategy, Tempus

12.30 LCOR mRNA Therapy for Breast Immuno-Oncology

Download the full event guide for full details.

Toni Celià-Terrassa, Principal Investigator, Hospital del Mar Medical Research Institute (IMIM)

Track: Clinical Development
Chair Moderator: Jason Zhang, CSO, RVAC Medicines

Accelerating the Best-in-Class mRNA-Based Vaccines to Combat New Variants of COVID-19

11.30 COVID-19 mRNA Vaccine Candidate Development at Moderna

Download the full event guide for full details.

Anne Aunins, Executive Director & Program Lead - COVID-19 Vaccines, Moderna

12.00 Targeted mRNA Vaccine Expression Using Combined Therapeutics’ Multi-Organ Protection (MOP) Technology Platform

Download the full event guide for full details.

Romain Micol, President, Co-Founder & CEO, Combined Therapeutics

12.30 PTX-COVID19-B mRNA Vaccine: Phase 2 Immunobridging Study vs. Comirnaty® - Topline Results

Download the full event guide for full details.

Aleksandra Pastrak, CMO, Providence Therapeutics

Track: CMC
Chair Moderator: Amin Khan, Chief Science Advisor, Afrigen Biologics

Overcoming mRNA Upstream & Downstream Process Development Hurdles for Efficient Manufacturing

11.30 Harnessing Plasmid DNA Manufacturing to Improve Quality & Impact on mRNA Drug Substance in the In Vitro Transcription Reaction

Download the full event guide for full details.

Lusheng Fan, Investigator,, GeneLeap Biotech

12.00 Overcoming Bottlenecks in mRNA Manufacturing

Download the full event guide for full details.

Pierre Catignol EVP & Head of Manufacturing, Samsung Biologics

12.30 Overcoming Scale-Up & Tech Transfer Hurdles in mRNA Manufacturing

Download the full event guide for full details.

Bill Grier, Associate Director – Drug Substance Process Development, Omega Therapeutics

Track: Logistics
Chair Moderator: Petro Terblanche, Managing Director, Afrigen Biologics

Advancing Supply Chain Hurdles for Optimal Raw Material Availability & Sourcing

11.30 Opportunities for mRNA Supply Chain

Download the full event guide for full details.

Gregory Troiano, Head of cGMP Strategic Supply & Operations - mRNA Center of Excellence, Sanofi

12.00 Session Reserved for Ziccum

Download the full event guide for full details.

12:30 Revolutionizing Pandemic Response: Harnessing the Power of mRNA Innovations to Achieve 100 days Mission of Vaccines Development

Download the full event guide for full details.

Arun Kumar, Preclinical Vaccines Development Lead, CEPI

1.00 Lunch Break & Networking

Track: Discovery
Chair Moderator: AJ Bergman, CFO, Capricor Therapeutics

Evolving mRNA Drug Substance Design to Optimize Drug Effectiveness

2.00 Optimizing mRNA Synthesis to Enhance Effectiveness of mRNA Drugs & Vaccines

Download the full event guide for full details.

Becki Yi Kuang, Assistant Professor, The Hong Kong University of Science & Technology

2.30 Development of Novel mRNA Capping Agents Through Nucleoside Modifications

Download the full event guide for full details.

Jiancun (Larry) Zhang, CEO, Henovcom

3.00 Machine Learning Guided mRNA Design for Vaccine Development

Download the full event guide for full details.

Vikram Agarwal, Head of mRNA Platform Design Data Science - mRNA Center of Excellence, Sanofi

Track: Translation
Chair Moderator: Gregory Fiore, CEO, Exacis Biotherapeutics

Boosting the Development of Lung-Specific mRNA-Based Therapeutics

2.00 The Therapeutic Potential of mRNA in the Restoration of Endothelial Cell Function

Download the full event guide for full details.

Daniel Tondera, Head of Biology, Pantherna Therapeutics

2.30 Novel PCR-Based mRNA Drug Substance Manufacturing

Download the full event guide for full details.

Aditi Mehta, Associate Director; Head of mRNA Process & Delivery, MilliporeSigma

3.00 mRNA-Based Therapeutics for the Lung

Download the full event guide for full details.

Philip John Santangelo, Assistant Professor, Emory University School of Medicine

Track: Clinical Development
Chair Moderator: Jason Zhang, CSO, RVAC Medicines

Accelerating the Best-in-Class mRNA-Based Vaccines to Combat New Variants of COVID-19

2.00 Neoantigen Immunotherapy for Solid Tumors: Molecular Responses & Clinical Benefit in End-stage Patients

Download the full event guide for full details.

Matthew Hawryluk, Executive VP & CBO, Gritstone Bio

2.30 Insights From the Development of mRNA Vaccine Targeting Tumor Mutations

Download the full event guide for full details.

Gal Cafri, Immunotherapy & Genetic Engineering Group Leader, Sheba Medical Center

3.00 Panel Q&A – Ask Speakers Your Burning Questions

Download the full event guide for full details.

Matthew Hawryluk, Executive VP & CBO, Gritstone Bio

Gal Cafri, Immunotherapy & Genetic Engineering Group Leader, Sheba Medical Center

Track: CMC
Chair Moderator: Amin Khan, Chief Science Advisor, Afrigen Biologics

Next Generation Strategies for Analytical Considerations for mRNA Drug Product Development

2.00 Analytical Characterization of mRNA-based Therapeutics & Vaccines

Download the full event guide for full details.

Andreas Kuhn, SVP – RNA Biochemistry & Manufacturing, BioNTech SE

2.30 Key Considerations for mRNA Process Optimization to Accelerate Path to Clinic

Download the full event guide for full details.

Venkata Indurthi, CSO, Aldevron

3.00 Harnessing the Power of Capillary Electrophoresis for the Analytical Characterization of mRNA

Download the full event guide for full details.

Kathir Muthusamy, Associate Director, Regeneron Pharmaceuticals

Track: Logistics
Chair Moderator: Petro Terblanche, Managing Director, Afrigen Biologics

Improving Cost Effectiveness of mRNA Production & Cold-Chain Storage Requirements for the Ultimate Supply Chain

2.00 Messenger RNA Bioproduction

Download the full event guide for full details.

Chantal Pichon, Professor, University of Orleans

2.30 Building Ultra-Low Cold Chain Capacity in Developing Countries

Download the full event guide for full details.

Jan Komrska, Contracts Manager – Supply Division, UNICEF

3.00 Panel Q&A – Ask Speakers Your Burning Questions

Download the full event guide for full details.

Gregory Troiano, Head of cGMP Strategic Supply & Operations - mRNA Center of Excellence, Sanofi

Vishal Khanderia, VP - Supply Chain, Beam Therapeutics

3.30 Tech Slam

Synopsis

Untitled design (9).png

Unraveling the Complex mRNA Landscape: Exploring Opportunities for Future Collaborations

4:00 pm Biopharma Partnerships Panel Exploring the Future of mRNA Investment & Collaborations

John Androsavich Head of Global Ribonucleic acid Emerging Science Lead, Pfizer
Pierre Cote Head of Strategic Partnership and Innovation Management, Sanofi
Nathaniel Wang Chief Executive Officer & Co-Founder, Replicate Bioscience
Matthew Hawryluk Executive Vice President & Chief Business Officer, Gritstone bio, Inc.
AJ Bergmann Chief Financial Officer, Capricor
June Kim CMC Lead, CEPI
Tamar Grossman Vice President & Head Of Ribonucleic Acid, Global Gene Therapy & Delivery, The Janssen Pharmaceutical

Synopsis

Download the full event guide for full details.

4:45 pm When Molecules Grow Up: Adaptations & Considerations for Your Manufacturing Strategies

David Sokolowski Nucleic Acid Therapeutics & Global Workflow Manager, Cytiva

Synopsis

Download the full event guide for full details.

5:15 pm A Look at the Past, Present & Future of mRNA Therapeutics

Ioana Panait Research Analyst, Beacon Intelligence

Synopsis

Download the full event guide for full details.

5:45 pm Chair’s Closing Remarks

Tamar Grossman Vice President & Head Of Ribonucleic Acid, Global Gene Therapy & Delivery, The Janssen Pharmaceutical

July 26-28, 2023 | Boston, MA

Day Two

7.00am Registration & Morning Coffee

8:05 am Chair’s Opening Remarks

Emergence of mRNA-Based Therapeutics & Vaccines 2.0

8:15 am Biopharma Leaders’ Fireside Chat – Evaluating Progress of mRNA Therapies in 2023: Where are we Succeeding & Where are the Gaps?

Synopsis

9:00 am Moderna’s mRNA-1345 Vaccine in Older Adults

Synopsis

9:30 am BioNTech’s Update on mRNA-Based Vaccines & Other mRNA-Based Therapeutics in Clinical Development

Synopsis

10:00 am Assessing the Industry’s Landscape & Preparing for the Future

Synopsis

10.30 Morning Break & Speed Networking

1.00 Lunch Break & Networking

3.30 Tech Slam

Synopsis

Unraveling the Complex mRNA Landscape: Exploring Opportunities for Future Collaborations

4:00 pm Biopharma Partnerships Panel Exploring the Future of mRNA Investment & Collaborations

Synopsis

4:45 pm When Molecules Grow Up: Adaptations & Considerations for Your Manufacturing Strategies

Synopsis

5:15 pm A Look at the Past, Present & Future of mRNA Therapeutics

Synopsis

5:45 pm Chair’s Closing Remarks

5:50 pm End of Day One

VENUES

LOCATION

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

SEARCH